Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Kestra Medical Technologies (KMTS) Payables (2024 - 2026)

Kestra Medical Technologies (KMTS) has disclosed Payables for 3 consecutive years, with $24.0 million as the latest value for Q1 2026.

  • Quarterly Payables fell 6.37% to $24.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $24.0 million through Jan 2026, down 6.37% year-over-year, with the annual reading at $24.0 million for FY2025, 0.29% changed from the prior year.
  • Payables for Q1 2026 was $24.0 million at Kestra Medical Technologies, up from $20.2 million in the prior quarter.
  • The five-year high for Payables was $25.7 million in Q1 2025, with the low at $18.6 million in Q3 2025.
  • Average Payables over 3 years is $22.7 million, with a median of $23.9 million recorded in 2024.
  • The sharpest move saw Payables grew 0.29% in 2025, then decreased 6.37% in 2026.
  • Over 3 years, Payables stood at $23.9 million in 2024, then fell by 15.42% to $20.2 million in 2025, then increased by 18.87% to $24.0 million in 2026.
  • According to Business Quant data, Payables over the past three periods came in at $24.0 million, $20.2 million, and $18.6 million for Q1 2026, Q4 2025, and Q3 2025 respectively.